foxo4 dri senolytic 2023 2024 The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI Molecular modelling of the FOXO4-TP53
Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases[v1] Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



